1 active trials 0 recruiting 1 disease areas 2 changes in 30 days
| Phase 2 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2 | ||||
| NCT04006522 | 89Zr-DFO-Atezolizumab ImmunoPET/CT in Patients With Locally Advanced or Metastatic Renal… | Renal Cell Carcinoma | Active, Not Recruiting | 2026-08-31 |
Kidney Cancer (1)